2015 annual financial data
Voyager Therapeutics 2015 Operating margin
Direct answer
Operating margin was -116.85%.
Operating income was -20,254,000 USD and net income was -29,672,000 USD.
Operating cash flow was 41,299,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,334,000 USD
- Operating income
- -20,254,000 USD
- Net income
- -29,672,000 USD
- Operating cash flow
- 41,299,000 USD